RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

EOG Resources Inc. (NYSE:EOG) received an upgraded stock rating from RBC Capital Markets, moving from Sector Perform to Outperform. Alongside the rating change, EOG Resources also saw its price target ...

Coca-Cola's Q4 exceeded expectations amid strong "fundamentals" despite currency headwinds and a market share grab from its ...

We recently compiled a list of the 11 Best Gig Economy Stocks to Buy According to Hedge Funds. In this article, we are going ...

RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

Find insight on BP in the latest Market Talks covering energy and utilities.

We recently published a list of 10 Mid-Cap IT Stocks Outperforming The Market In 2025. In this article, we are going to take ...

Analysts suggest hedge fund will want board room shake-up, E&P focus, asset sales, spin-offs and could 'smoke out' corporate ...

TD holds 184.7 million shares in Charles Schwab, worth roughly $15.4 billion (22.07 billion Canadian dollars) based on the ...